Kerala’s health department under Minister Veen George ordered that no medicines without a prescription should be given to children under 12 years. The decision was taken in the middle of deaths in children in Madhya Pradesh and Rajasthane because of the contaminated syrup cough.
According to PTI, George said that drugs should not be issued even by the old regulation.
Also read | Madhya Pradesh Cough Syrup Deaths: Doctor arrested, probe probe
A three -member expert was reportedly established to study the use of cough drug and formulate new instructions.
Ministers of Health Keral Veen George said the panel includes a state controller for drugs, a children’s node clerk and the President of the State Unit of the Indian Academy of Pediatrics. “Its finding will help formulate new instructions for using cough syrup in children,” the minister said.
Also read | Mint Explanation Does India have a problem with the syrup cough?
The sale of the problematic COLDRIF syrup was immediately suspended, although the officials confirmed that the benefit was not distributed in Kerala.
The contaminated dose of syrup was reportedly distributed in Tamil Nadu, Odisha, Madhya Pradesh and Puduchherry, added PTI report.
“There were no problems associated with cough syrup for children in Kerala,” the Minister said in his statement.
Also read | 14 children of the dead in the MP: Doctor arrested; Fir against him, the manufacturer of the syrup cough
COLDRIF Cough syrup responsible for the death of children?
About 14 deaths of children in Madhya Pradesh, where the government suspended three officials and transferred the drug controller.
These deaths due to suspicion of kidney failure were reported from Chhindware in Madhya Pradesh in a month, PTI press agency reported.
It was found that the syrup coughs made in Tamil Nadu is dangerously falsified by the highly poisonous substance of diethylene glycol (DEG).
Also read | The resort starts the probe when six children die of contaminated syrup coughs
Several states take steps: What are they doing?
Tragic death caused national health warnings, which led to the suspension of officials in Madhya Pradesh, arrest, national stock confiscations and immediate, strict changes in the instructions for drugs in countries such as Kerala and Karnataka.
Karnataka
In the carnation, the Minister of Health Dinesh Gunda Rao was a warning, and the officials verified whether the “non -standard” syrup was sold in the state.
He clarified that there was no such incident in Karnataka, but the samples of all syrup brands are collected for preventive testing.
Telangana
Telangan’s government ordered all district medical and medical officials to sensitize the public for a toxic warning of syrup and strictly implement the advice of the Ministry of Health of the Trade Union against prescribing or issuing coughs and cold drugs to children up to two and generally under five years.
Tamil
Tamil Nadu, where the manufacturing unit (Sresan Pharmaceutical, Kancheepuram) is located, has already forbidden the sale of Coldy syrup after receiving reports on deaths in Madhya Pradesh and similar deaths in Rajasthan.
Determination of the drug Tamil Nadu that the sample was “falsified” with diethylene glycol (DEG), formed the basis of a national ban.
Chhattisgarh
Chhattisgarh’s health department has issued immediate instructions to all main medical and medical officers (CMHO) and civil surgeons across the districts to strictly promote the center of the center.
The Health Commissioner said that cough medicines and cold medicines should only be administered on the basis of a prescription and that no negligence will be tolerated.
Maharashtra
In the Mahashtra, food and drug administration (FDA) has appealed to the public and chemists to stop the sale or use of the CODRIF syrup from the specific benefit identified by the Tamil Nadu authorities for the “harmful”.
He also called on them to report any incidents to the closest drug control authority.
Officials coordinate with Tamil Nadu to monitor the distribution of the affected benefits.
All drug inspectors and assistants were ordered to highlight retailers, wholesalers and hospitals to freeze the available stocks immediately, the FDA said in its statement.
In the middle of concerning the quality of syrups coughs, the Ministry of Health of the Union on Sunday stressed the need that all drug manufacturers adhere to the revised plan M and warned that strict measures would be taken against the violators.
The crisis emphasizes critical failure in the quality and safety of the drug and the standard central drug control organization, the National Disease Control Center, and the state regulators have joined the hand to prevent similar tragedies.
(Tagstotranslate) cough syrup death
